Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib

Bye, AP; Kriek, N; Sage, T; Rawlings, SJ; Prodger, C; Kesavan, M; Lees, C; Booth, S; Cowen, LG; Shefferd, K; Desborough, MJ; Gibbins, JM; Eyre, TA

Bye, AP (通讯作者),St Georges Univ, Mol & Clin Sci Res Inst, London, England.;Bye, AP (通讯作者),Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, England.

HAEMATOLOGICA, 2023; 108 (5): 1429